Introduction Cardiovascular disease (CVD) is the leading cause of death in the United States. Specific risk factors increase the chances of developing CVD including diabetes, hypertension, dyslipidemias, smoking and family history. Additionally, targeted treatments have been demonstrated to prevent first or recurrent events including use of statins, beta blockers, ACE inhibitors, diuretics, and aspirin. Utilization of these treatments may differ in different populations, and regions. The purpose of this study was to compare risk factor profiles and treatment adequacy in urban and rural health care settings.
Methods A retrospective chart review was performed on 200 randomly selected charts, 100 from each setting, in patients with (50 from each location) CVD and 50 without CVD. Specific criteria were recorded from each chart including lipid levels, BP, medications, diabetes status, and smoking status.
Results There were no differences in rates of diabetes, HTN, dyslipidemias, or tobacco use between the two groups. However there were significant differences in targeted treatments (Table).
CCB (calcium channel blocker), BB (beta blocker), ASA (aspirin), ACEI (ACE inhibitor), ARB (angiotensin receptor blocker)
Conclusion We have demonstrated that despite having similar risk factors, patients in a rural area receive less CVD targeted treatment compared to cohorts in an urban setting. Reallocation of health care resources to rural areas may be necessary to offset these differences. Further studies to understand this health care disparity are needed.